Evidence map›Paper›PMID 30130491›Full record

ArticleAnalytical biochemistry2018

Peptide ligand-based ELISA reagents for antibody detection.

Ewa Heyduk, Rachel Hickey, Nicola Pozzi, Tomasz Heyduk

Abstract read
In one paragraph

Article in Analytical biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evaluation of the Antigenic Potential of Epitopes Derived FromBioinformatics and biology insights · 2025
    Article
  5. Article
  6. Article
  7. A Blood Test for the Diagnosis of Multiple Sclerosis.International journal of molecular sciences · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ewa HeydukEdward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Medical School, 1100 S. Grand Blvd, St. Louis, MO, 63104, USA.
Rachel HickeyEdward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Medical School, 1100 S. Grand Blvd, St. Louis, MO, 63104, USA.
Nicola PozziEdward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Medical School, 1100 S. Grand Blvd, St. Louis, MO, 63104, USA.
Tomasz HeydukEdward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Medical School, 1100 S. Grand Blvd, St. Louis, MO, 63104, USA. Electronic address: tomasz.heyduk@health.slu.edu.

Funding

New Bioanalytical Methods Based on Next Generation SequencingR01GM109974 · NIGMS · SAINT LOUIS UNIVERSITY · PI HEYDUK, TOMASZ · 2015 to 2018
$1.2M
NIGMS NIH HHS R01 GM109974
6 · The paper itself

Abstract

Detection of specific antibodies has numerous research, therapeutic and diagnostic applications. Short peptide ligands that bind specifically to antibodies with continuous epitopes can be derived from epitope mapping experiments. Short peptide ligands (mimotopes) specific to antibodies with discontinuous epitopes can be identified by screening complex peptide libraries. In an effort to enhance practical utility of such peptide ligands, we describe here a simple approach to turn such target antibody-specific peptide ligands into specific ELISA detection reagents. We show that a simple addition of biotinylated peptide ligands to commonly available horseradish peroxidase (HRP)-labeled streptavidin (or HRP-anti-biotin antibody), or digoxigenin-labeled peptides to HRP-anti-digoxigenin antibody detection reagents transformed these generic detection reagents into sensitive target antibody-specific reagents. ELISA assays performed using these reagents exhibited excellent analytical properties indicating their practical utility for antibody detection. One generic detection reagent can be readily transformed into many different specific ELISA reagents by a simple mix and match design using an appropriate target-specific peptide ligand. Simplicity of preparation of these ELISA reagents for detecting antibodies should facilitate their practical applications.

Indexed as

AntibodiesBiotinylationEnzyme-Linked Immunosorbent AssayIndicators and ReagentsLigandsPeptidesAntibodiesIndicators and ReagentsLigandsPeptidesAntibodyDetectionELISAPeptide

Identifiers

PMID30130491
PMCPMC6185743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.